| Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398 SH Bae, ES Jung, YM Park, BS Kim, BK Kim, DG Kim, WS Ryu Clinical Cancer Research 7 (5), 1410-1418, 2001 | 307 | 2001 |
| Hepatitis B virus X protein is essential for the activation of Wnt/β‐catenin signaling in hepatoma cells MY Cha, CM Kim, YM Park, WS Ryu Hepatology 39 (6), 1683-1693, 2004 | 278 | 2004 |
| Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion H Wang, WS Ryu PLoS pathogens 6 (7), e1000986, 2010 | 234 | 2010 |
| Assembly of hepatitis delta virus particles WS Ryu, M Bayer, J Taylor Journal of Virology 66 (4), 2310-2315, 1992 | 228 | 1992 |
| Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels C Ko, A Chakraborty, WM Chou, J Hasreiter, JM Wettengel, D Stadler, ... Journal of hepatology 69 (6), 1231-1241, 2018 | 218 | 2018 |
| DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids H Wang, S Kim, WS Ryu Journal of virology 83 (11), 5815-5824, 2009 | 140 | 2009 |
| Ribonucleoprotein complexes of hepatitis delta virus WS Ryu, HJ Netter, M Bayer, J Taylor Journal of virology 67 (6), 3281-3287, 1993 | 127 | 1993 |
| Simian virus 40 late transcripts lacking excisable intervening sequences are defective in both stability in the nucleus and transport to the cytoplasm WS Ryu, JE Mertz Journal of Virology 63 (10), 4386-4394, 1989 | 126 | 1989 |
| Comparative analysis of antiviral efficacy of FDA‐approved drugs against SARS‐CoV‐2 in human lung cells M Ko, S Jeon, WS Ryu, S Kim Journal of medical virology 93 (3), 1403-1408, 2021 | 121 | 2021 |
| Evidence that the 5′-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA JK Jeong, GS Yoon, WS Ryu Journal of virology 74 (12), 5502-5508, 2000 | 115 | 2000 |
| Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis YC Kim, KS Song, G Yoon, MJ Nam, WS Ryu Oncogene 20 (1), 16-23, 2001 | 112 | 2001 |
| Versatile PCR-mediated insertion or deletion mutagenesis J Lee, HJ Lee, MK Shin, WS Ryu Biotechniques 36 (3), 398-400, 2004 | 101 | 2004 |
| Virus life cycle WS Ryu Molecular virology of human pathogenic viruses, 31, 2017 | 99 | 2017 |
| DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level C Ko, S Lee, MP Windisch, WS Ryu Journal of virology 88 (23), 13689-13698, 2014 | 94 | 2014 |
| Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression MY Cha, DK Ryu, HS Jung, HE Chang, WS Ryu Journal of general virology 90 (4), 978-986, 2009 | 85 | 2009 |
| Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection SH Choo, HS So, JM Cho, WS Ryu Journal of general virology 76 (9), 2337-2341, 1995 | 79 | 1995 |
| The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide C Ko, WJ Park, S Park, S Kim, MP Windisch, WS Ryu Antiviral therapy 20 (8), 835-842, 2015 | 72 | 2015 |
| Insertion and deletion mutagenesis by overlap extension PCR J Lee, MK Shin, DK Ryu, S Kim, WS Ryu In Vitro Mutagenesis Protocols: Third Edition, 137-146, 2010 | 72 | 2010 |
| HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression W Lim, SH Kwon, H Cho, S Kim, S Lee, WS Ryu, H Cho Journal of molecular medicine 88, 359-369, 2010 | 66 | 2010 |
| Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells A König, J Yang, E Jo, KHP Park, H Kim, TT Than, X Song, X Qi, X Dai, ... Journal of hepatology 71 (2), 289-300, 2019 | 58 | 2019 |
